Position in MRK
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,141,851
+$159,323 QoQ
Shares Held
8,886
+8.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.27%
of 13F equity value
Holder Rank
#2,007
of 3,769 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Glen Eagle Advisors, LLC holds $41,817,560 across 12 Drug Manufacturers - General names. MRK ranks #4 (2.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
113,724 | $28,882,484 | |
| 2 | ABBV |
AbbVie Inc.
|
21,140 | $5,319,669 | |
| 3 | LLY |
ELI LILLY & Co
|
3,599 | $4,316,748 | |
| 4 | MRK |
Merck & Co., Inc.
This page
|
8,886 | $1,141,851 | |
| 5 | PFE |
Pfizer Inc
|
30,849 | $742,843 | |
| 6 | AMGN |
Amgen Inc
|
1,750 | $633,710 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
4,641 | $267,414 | |
| 8 | GSK |
GSK plc
|
4,548 | $238,406 |
All Filings in MRK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,141,851 | 8,886 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $982,528 | 8,168 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $827,975 | 7,866 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $682,434 | 8,131 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $629,242 | 7,949 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $764,485 | 8,517 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $863,386 | 8,679 | Shares | Sole | 2025-02-18 | |
| 2024-09-30 | $985,473 | 8,678 | Shares | Sole | 2024-11-15 | |
| 2024-06-30 | $1,054,404 | 8,517 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $1,184,119 | 8,974 | Shares | Sole | 2024-07-03 | |
| 2023-12-31 | $988,593 | 9,068 | Shares | Sole | 2024-08-13 | |
| 2023-09-30 | $938,080 | 9,112 | Shares | Sole | 2024-08-13 | |
| 2023-06-30 | $1,485,646 | 12,875 | Shares | Sole | 2024-08-13 | |
| 2023-03-31 | $1,547,336 | 14,544 | Shares | Sole | 2024-08-13 | |
| 2022-12-31 | $874,396 | 7,881 | Shares | Sole | 2024-08-13 | |
| 2022-09-30 | $670,874 | 7,790 | Shares | Sole | 2024-08-13 | |
| 2022-06-30 | $696,629 | 7,641 | Shares | Sole | 2024-08-13 | |
| 2022-03-31 | $592,318 | 7,219 | Shares | Sole | 2024-08-13 | |
| 2021-12-31 | $569,895 | 7,436 | Shares | Sole | 2024-08-13 | |
| 2021-09-30 | $604,860 | 8,053 | Shares | Sole | 2024-08-13 | |
| 2021-06-30 | $626,281 | 8,053 | Shares | Sole | 2024-08-13 | |
| 2021-03-31 | $594,903 | 7,717 | Shares | Sole | 2024-08-13 | |
| 2020-12-31 | $629,287 | 7,693 | Shares | Sole | 2024-08-13 | |
| 2020-09-30 | $739,914 | 8,920 | Shares | Sole | 2024-08-13 | |
| 2020-06-30 | $653,438 | 8,450 | Shares | Sole | 2024-08-13 | |
| 2020-03-31 | $651,989 | 8,474 | Shares | Sole | 2024-08-13 | |
| No filing history on record for this holder in this stock. | ||||||